AstraZeneca PLC is 79.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $3.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRNX | AZN |
|---|---|---|
| Market cap | $3.62 B | $286.27 B |
| US-listed rank | #1659 | #45 |
| Revenue (latest FY) | $7.70M | - |
| Net income (latest FY) | -$465.30M | - |
| Net margin | -6046.0% | - |
| SEC filings | 670 | 1,004 |
AstraZeneca PLC is 79.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $3.62 B).
Full pages: Crinetics Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.